Trial intelligence / Profile preview

Intraoperative goal-directed fluid therapy in lean versus obese gynecologic surgery patients

2006-002333-21Phase 4Completed

Sponsor
Medical University of Vienna
Start
Jun 2006
Modality
Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, randomised, open-label trial of Volulyte and lactated ringer's solution (4 arms), sponsored by Medical University of Vienna. Primary endpoint: Tissue oxygen tension after surgery. Started Jun 2006; status: completed.

02

Drugs

Volulytelactated ringer's solution

Beyond the preview

Go deeper on 2006-002333-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-002333-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call